Investing.com - Bristol-Myers Squibb (NYSE:BMY) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Bristol-Myers Squibb announced earnings per share of $1.63 on revenue of $10.54B. Analysts polled by Investing.com anticipated EPS of $1.49 on revenue of $10.33B.
Bristol-Myers Squibb shares are down 21% from the beginning of the year and are trading at $65.43 , down-from-52-week-high.They are under-performing the AEX which is down 5.31% from the start of the year.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday, October 27, 2020 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar